BIOLASE Introduces Dentistry’s First-Ever Practice Growth Guarantee™ with the Launch of the New WaterLase iPlus™ 2.0

Download as PDF

The Newest Version of the World’s Most Preferred All-Tissue Laser Also Includes the New SureFire™ YSGG Delivery System and the Powerful REPaiR™ Laser Perio App

IRVINE, Calif. & CHICAGO--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers that is committed to elevating the total dental experience, today introduced dentistry’s first-ever Practice Growth Guarantee with the launch of the new, advanced WaterLase iPlus 2.0.

WaterLase iPlus 2.0, the next generation of the world’s most-preferred all-tissue laser, will debut this week in the BIOLASE booth (#601) at the Chicago Dental Society’s Mid-Winter Meeting at McCormick Place West. The new laser includes important innovations and improvements resulting in satisfied patients and dental practice growth. WaterLase iPlus 2.0 also marks the debut of the SureFire YSGG Delivery System which ensures greater uptime and routine use for dentists. In addition, the laser integrates REPaiR as an app for minimally invasive treatment of periodontitis.

“The groundbreaking Practice Growth Guarantee and new WaterLase iPlus 2.0 stem from the disciplined innovation that is at the core of the new BIOLASE,” said President and CEO Jeffrey M. Nugent. “Because we believe in its value and quality improvements, we are standing behind WaterLase iPlus 2.0 by making it the first dental laser ever backed by a guarantee to provide growth in dental practices. This bold and exciting guarantee demonstrates the commitment to our customers’ success with the new WaterLase iPlus 2.0 laser.”

The unique Practice Growth Guarantee is an assurance that WaterLase iPlus 2.0 will make a difference by enhancing the patient experience and generating practice growth through routine use.

“The Practice Growth Guarantee and the new WaterLase iPlus 2.0 represent another key step in the transformation of BIOLASE,” Nugent added. “We have listened to customers’ feedback, and we believe this new laser will elevate the total dental experience. The results our successful customers are seeing in their practices, ranging from more satisfied patients to very positive clinical outcomes, gives us the confidence to guarantee their growth with our new breakthrough laser,” said Mr. Nugent.

Internationally, version 2.0 of the WaterLase iPlus will launch at Pacific Dental Conference in Vancouver, British Columbia, March 5-7, 2015 and at the world’s largest dental event, the International Dental Show (IDS) in Cologne, Germany, March 10-14, 2015.

WaterLase iPlus 2.0

The WaterLase iPlus 2.0 offers key refinements and updates, including:

  • Upgraded components to improve overall quality and performance during daily, routine use.
  • Optimized procedure pre-sets to help dentists achieve clinical success more consistently.
  • New tips added to the award-winning clinical menu, including the popular RFPT5 and RFPT8 tips, which are key components in the new REPaiR periodontal protocol.
  • Improved “i” button on the main screen for easier access to help screens.

SureFire YSGG Delivery System

The SureFire YSGG Delivery System, which results in more dependability and uptime for the dentist, includes:

  • Redesigned optics that can more efficiently deliver precise amounts of laser energy to cut enamel, dentin and bone, in addition to the soft tissue capabilities for which the WaterLase® franchise is known.
  • A replaceable, disposable shield that protects the vital optical components in the SureFire fiber.

REPaiR for Successfully Treating Periodontitis

The REPaiR laser perio app:

  • Was based on years of clinical development by a team of periodontists and dentists from around the world including noted periodontist, educator and innovator Dr. Samuel L. Low.
  • Is an achievable, repeatable minimally invasive procedure that is less traumatic than traditional surgical techniques and delivers better and gentler experiences for patients.
  • Includes clinical illustrations and pre-programmed settings for each step of the protocol to ensure consistent results.

To learn more about the Practice Growth Guarantee and WaterLase iPlus 2.0, visit BIOLASE Booth #601 at Chicago Dental Society’s Mid-Winter Meeting at McCormick Place, February 26-28, 2015 or visit www.biolase.com.

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers. BIOLASE's products are focused on technologies that advance the practice of dentistry and medicine and offer benefits and value to healthcare professionals and their patients. The Company's proprietary laser products incorporate approximately 250 patented and 100 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 27,600 laser systems. Laser products under development address the Company's core dental market and other adjacent medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

BIOLASE, WaterLase, and EPIC are trademarks of BIOLASE, Inc.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements contained in this press release that refer to BIOLASE's estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements in this press release concerning prospects related to BIOLASE's strategic initiatives and anticipated financial performance. Forward-looking statements can also be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations regarding existing trends, our strategic initiatives, the closing of the private placement and expected use of proceeds and speak only as of the date of this release. Actual results may differ materially from BIOLASE’s current expectations depending upon a number of factors affecting BIOLASE’s business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that may be detailed, from time-to-time, in BIOLASE's reports filed with the SEC. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements contained herein.

Allen & Caron Inc
Rene Caron (Investors)
949-474-4300
rene@allencaron.com
or
Len Hall (Media)
len@allencaron.com
949-474-4300

Source: BIOLASE, Inc.

Released February 26, 2015